top of page

ABOUT PATA

Our Mission

 

The Psilocybin Assisted Therapy Association's (PATA) mission is to promote the advancement of Psilocybin-Assisted Therapy.

 

Our goals:

 

  • Inform the general public and advocate for the use of PAT 

  • Reduce the stigma of using psilocybin, the active ingredient in "magic mushrooms," in general and as a therapeutic modality

  • Provide clinical resources and information to consumers and mental health therapists

 

 

 Our primary programs include: 

 

  1. Educating the community about the benefits of PAT, thereby reducing the stigma of using psilocybin therapeutically and for personal growth.

  2. Offering a free Self-Assessment Tool that provides clients with the best means to reach their therapeutic outcomes with a focus on mental health therapy.

  3. Providing our Psilocybin-Assisted Therapy Association (PATA) Model supported by clinical resources and information to both consumers and therapists interested in PAT.

  4. Equipping consumers with guidelines and resources enabling them to choose the best provider for their individual therapeutic needs. Including information about Oregon Psilocybin Services.

  5. Advocating for the advancement of PAT and psychedelics from the local to international levels.

Core Beliefs

 

  • Psilocybin as a natural product has an extraordinary ability when taken to help individuals with issues such as depression, anxiety, substance use, and trauma.

    • To achieve clinical improvements, consumers should include licensed mental health professionals (LMHP) in their PAT process.

  • Improved mental health is the primary outcome of all of our programs.

    • LMHPs should be involved in a consumer’s PAT process if their goals are mental health focused.

  • PAT is a team approach. As our model describes, LMHPs and psychedelic professionals both work for the consumers' best interests.

    • Helping consumers heal is the ultimate objective regardless of personal or professional bias.

  • Educational resources are psilocybin-focused.

    • Psychedelics are not the same, thus resources and training should not be the same.

  • Consumers should be educated on the potential for needing post-experience integration or integration therapy, regardless of initial intention.

    • Intense and challenging experiences may occur, and an integration professional can help with integration, but only .a psychedelic-friendly LMHP should provide integration therapy

  • Education leads to personal empowerment for consumers to address mental health using PAT and for professionals to help address a national mental health crisis.

    • Education leads to personal and professional empowerment that will result in LMHPs providing better mental health care and consumers having increased potential for improved mental health outcomes.

  • LMHPs have existing training and mastery of how to provide mental health therapy. Their specialties and existing modalities are what are used to help their clients.

    • We aim to reduce the stigma and concerns that additional mental health training is needed for an LMHP to perform their work.

  • LMHPs anywhere in the US can participate in PAT while remaining compliant for their licensure using a harm reduction approach.

    • LMHPs do not need to be present during the psilocybin experience or participate in the logistical set & setting.

  • LMHPs do not need to have personal experience with or the desire to personally use psilocybin to provide mental health care to a client/consumer.

    • To best serve consumers in the global mental health crisis, personal experience is a benefit but should not exclude a therapist from providing PAT integration therapy.

    • An all-or-nothing approach is not consumer-focused.

bottom of page